Compare JPMorgan Chase & Co (JPM) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs Oscar Health Inc — how do they compare? JPMorgan Chase & Co trades at $342.21 (market cap $900.78B), while Oscar Health Inc trades at $30.53 (market cap $8.92B). The key difference: JPMorgan Chase & Co is far larger — about 101× Oscar Health Inc's market cap, and JPMorgan Chase & Co pays a 1.77% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| JPM | OSCR | |
|---|---|---|
Market Cap | $900.78B | $8.92B |
Volume | 10,479,943 | — |
Sector | Financials | Health |
52-Week High | $346.91 | $32.18 |
52-Week Low | $282.84 | $10.85 |
Dividend Yield | 1.77% | — |
Enterprise Value | — | $4.55B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase & Co. (JPM) trades at $342.57, up 0.43% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with a P/E of 14.52 and net income margin of 33.4%, though Q4 2025 EPS missed expectations. Recent news highlights CEO Jamie Dimon's economic warnings and upcoming Q1 2026 earnings, with analyst consensus leaning bullish.
JPM offers upside to the $372.73 consensus price target, driven by earnings beats and sector resilience, but faces risks from geopolitical tensions, cybersecurity threats, and volatile cash flows. Investors should weigh solid profitability against macroeconomic headwinds highlighted in recent shareholder communications.
Oscar Health (OSCR) trades at $29.60, up 1.72% today, showing mixed signals with a bullish technical trend but bearish oscillators. The company reported revenue growth to $11.70B in 2025, though net income remains negative at -$443.15M. Recent earnings beat expectations in Q1 2026 with EPS of $2.07, while analyst sentiment is divided with a consensus price target of $24.67. Positive cash flow trends and media coverage highlight growth potential amid ongoing profitability challenges.
Outlook: OSCR offers growth exposure in health insurance with strong revenue expansion and cash flow, but profitability risks persist. Investment opportunity lies in execution toward breakeven, while risks include margin pressure and competitive threats. The stock's current price above consensus target suggests cautious optimism is warranted.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
